文献速递心脑血管急症

L-α-甘油磷酰胆碱使用与10年后卒中风险的关联

Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years.
PubMed 文献 · JAMA Netw Open · 2021-11-01
一句话结论50岁以上人群使用α-GPC与10年总卒中、缺血性卒中和出血性卒中风险升高相关,且呈剂量-反应关系。

该研究基于韩国国民健康保险服务数据,纳入12 008 977名50岁以上无卒中或阿尔茨海默病的参与者,回顾性分析2006-2008年间α-GPC处方与2009年1月1日至2018年1月31日卒中的关联。与未使用者相比,α-GPC使用者总卒中风险升高(aHR 1.46;95%CI 1.43-1.48),缺血性卒中(aHR 1.36;95%CI 1.33-1.39)和出血性卒中(aHR 1.36;95%CI 1.28-1.44)风险也升高;倾向性匹配后结果一致。α-GPC摄入量增加与总卒中风险升高呈剂量-反应关系。作者认为需进一步研究α-GPC潜在升高脑血管风险的机制。

要点

  • 在50岁以上无卒中或阿尔茨海默病人群中,α-GPC使用者较未使用者总卒中风险升高(aHR 1.46;95%CI 1.43-1.48)。
  • α-GPC使用者缺血性卒中风险升高(aHR 1.36;95%CI 1.33-1.39),出血性卒中风险也升高(aHR 1.36;95%CI 1.28-1.44)。
  • 匹配所有协变量后,α-GPC使用者总卒中风险仍升高(aHR 1.43;95%CI 1.41-1.46),缺血性卒中(aHR 1.34;95%CI 1.31-1.37)和出血性卒中(aHR 1.37;95%CI 1.29-1.46)风险亦升高。
  • α-GPC摄入量增加与总卒中风险升高呈剂量-反应关系。
  • 作者认为未来需研究α-GPC潜在升高脑血管风险的机制。

适用人群与场景

  • 50岁及以上、无基础卒中或阿尔茨海默病的男性和女性(N=12 008 977),数据来自韩国国民健康保险服务。
  • α-GPC使用者指2006-2008年间被处方α-GPC者(n=108 877),未使用者为同期未处方者(n=11 900 100)。

研究设计与关键结果

  • 研究类型:基于人群的回顾性队列研究,使用韩国国民健康保险服务数据。
  • 样本量:12 008 977人,其中女性6 401 965人(53.3%);未使用者平均(SD)年龄61.6(9.4)岁,使用者68.3(10.0)岁;匹配队列两组平均(SD)年龄均为68.2(9.9)岁。
  • 主要终点:与未使用者相比,α-GPC使用者总卒中aHR 1.46(95%CI 1.43-1.48),缺血性卒中aHR 1.36(95%CI 1.33-1.39),出血性卒中aHR 1.36(95%CI 1.28-1.44)。
  • 匹配所有协变量后:α-GPC使用者总卒中aHR 1.43(95%CI 1.41-1.46),缺血性卒中aHR 1.34(95%CI 1.31-1.37),出血性卒中aHR 1.37(95%CI 1.29-1.46)。
  • 剂量-反应:α-GPC摄入量增加与总卒中风险升高呈剂量-反应关系。

证据类型、等级与局限

  • 证据类型:基于人群的回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: L-α glycerylphosphorylcholine (α-GPC, choline alphoscerate) is used globally by individuals older than 50 years based on its potential function as a precursor of acetylcholine. However, choline has previously been linked to a higher risk of cardiovascular disease via trimethylamine-N-oxide, a metabolite of choline by microbiota.

OBJECTIVE: To investigate the association between α-GPC use and subsequent 10-year stroke risk.

DESIGN, SETTING, AND PARTICIPANTS: A population-based, retrospective cohort study was conducted using data from the National Health Insurance Service of South Korea. Participants included men and women aged 50 years or older without underlying stroke or Alzheimer disease (N = 12 008 977).

MAIN OUTCOMES AND MEASURES: All participants were divided into whether they were prescribed α-GPC during 2006-2008. α-GPC users were matched with nonusers for all covariates to create a matched cohort. α-GPC use was further divided into durations less than 2, 2 to 6, 6 to 12, and more than 12 months of α-GPC prescriptions. The adjusted hazard ratios (aHRs) and 95% CIs for total stroke, ischemic stroke, and hemorrhagic stroke from January 1, 2009, to January 31, 2018, were calculated by multivariate Cox proportional hazards regression.

RESULTS: A total of 12 008 977 individuals (6 401 965 [53.3%] women) aged 50 years or older were included in the study. The mean (SD) age was 61.6 (9.4) years for nonusers and 68.3 (10.0) years for users, and that of the matching cohort was 68.2 (9.9) years for both groups. Compared with α-GPC nonusers (n = 11 900 100), users (n = 108 877) had a higher risk for total stroke (aHR, 1.46; 95% CI, 1.43-1.48), ischemic stroke (aHR 1.36; 95% CI, 1.33-1.39), and hemorrhagic stroke (aHR, 1.36; 95% CI, 1.28-1.44). After matching for all covariates, α-GPC users had a higher risk for total stroke (aHR, 1.43; 95% CI, 1.41-1.46), ischemic stroke (aHR, 1.34; 95% CI, 1.31-1.37), and hemorrhagic stroke (aHR, 1.37; 95% CI, 1.29-1.46). Increasing intake of α-GPC was associated with a higher risk for total stroke in a dose-response manner.

CONCLUSIONS AND RELEVANCE: In this cohort study, use of α-GPC was associated with a higher 10-year incident stroke risk in a dose-response manner after adjusting for traditional cerebrovascular risk factors. Future studies are needed to determine the possible mechanisms behind the potential cerebrovascular risk-elevating effects of α-GPC.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Lee G, Choi S, Chang J, et al. Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Netw Open. 2021. PMID: 34817582. doi:10.1001/jamanetworkopen.2021.36008

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。